Report

src

Global Traumatic Brain Injury Therapeutics Market Size, Share & Recession Impact Analysis, By Treatment (Immediate Emergency Care, Medications, and Surgery), By Route of Administration (Parenteral and Oral), By Patient Age (Children, Teenager and Elder), By Gender (Male and Female), By Cause of Injury (Falls, Motor Vehicle Traffic, Sports and Others), By End Users (Hospitals, Neurology Clinics, Independent Pharmacies and Others), and Regional Forecasts, 2023-2030

Customization
  • We provide customized solutions to cater to your specific requirement services any region, product, or any specific market segment.
The global traumatic brain injury therapeutics market size was valued at USD 152.3 billion in 2022. The market is projected to grow from USD 152.3 billion in 2022 to USD 204.1 billion by 2030, exhibiting a CAGR of 5.00% during the forecast period.
 
The primary driver fueling the expansion of the market for traumatic brain injury therapeutics is the need for extensive surgical procedures to treat and correct these injuries. The market for traumatic brain injury therapeutics is also anticipated to rise due to several technological developments and advancements, substantial research and development efforts, and many clinical trials to develop traumatic brain injuries. The market for traumatic brain injury therapeutics is growing, but in developing nations, there is a lack of understanding among diverse people and consumers of this treatment. Furthermore, the market for the traumatic brain injury therapeutics will have plenty of chances throughout the forecast above period due to the rise in auto accidents and sports-related injuries.
 
RECESSION IMPACT

The recession will significantly affect the market for traumatic brain injury therapeutics. Research and development of treatments for traumatic brain injury may receive less financing during a recession. The development of novel and cutting-edge treatments might be slowed down. A recession may cause people to struggle financially, making them less likely to seek treatment for traumatic brain injuries, diminishing the market for related treatments. In addition, many people may lose their jobs during a recession and, as a result, their healthcare coverage. The number of persons who can afford to get treatments for traumatic brain injury may decline.
 
DRIVING FACTORS

Increasing demand for efficient and high-quality manufacturing processes to drive market growth

One of the main factors propelling the market for TBI therapeutics is the rising prevalence of traumatic brain injury (TBI). The World Health Organization (WHO) reports that TBI is a leading global cause of death and disability. The prevalence of TBI is rising globally as a result of several factors, including an uptick in traffic accidents, sports-related injuries, and falls among the elderly. One of the main causes of TBI, particularly in low- and middle-income nations, is traffic accidents. The WHO estimates that 1.35 million people die annually as a result of traffic accidents and that up to 50 million additional individuals get non-fatal injuries, including TBI. Furthermore, the rising prevalence of TBI is also attributed to sports-related injuries. Thus, this is driving the market growth.
 
RESTRAINING FACTORS

High Cost of Traumatic Brain Injury Therapeutics to Limit Market Growth

Traumatic brain injury therapeutics can be expensive, which can be a big obstacle for individuals needing them. Depending on the extent of the injury, the kind of care required, and the patient's location, the cost of TBI therapy may change. Inpatient care, for instance, can be quite expensive, particularly for patients who need long-term rehabilitation and intense care. In addition, surgery and other procedures like brain imaging and monitoring might greatly increase the price of therapeutics. Furthermore, the cost of TBI therapeutics may also depend on the accessibility of specialized resources like hospitals and medical staff. Patients in rural areas or in low- and middle-income nations can have less access to specialized care, which could lead to increased travel and lodging expenses.
 
SEGMENTATION

By Treatment

Traumatic Brain Injury Therapeutics Market By Treatment
Based on treatment, the traumatic brain injury therapeutics market is segmented into immediate emergency care, medications and surgery. The medications category dominated the market in 2022. The signs and symptoms of TBI, such as pain, inflammation, and seizures, are frequently treated with medications. Medications like painkillers, anti-inflammatories, and anticonvulsants are frequently utilised. Medications are frequently employed to manage symptoms and stop future brain damage after traumatic brain injury (TBI). The precise symptoms and extent of the injury determine which drugs are recommended for TBI.
 
By Route of Administration

Based on route of administration, the traumatic brain injury therapeutics market is segmented into parenteral and oral. The oral category dominated the market in 2022. The most popular method of administering TBI treatments is oral. Patients can take the prescription by mouth with or without food when prescribed by their doctor. For stable patients who can take oral drugs, this method of administration is the best because it is practical and simple to administer.
 
By Patient Age

Based on patient age, the traumatic brain injury therapeutics market is segmented into children, teenager, and elder. The elder category dominated the market in 2022. Patients who have experienced a traumatic brain injury and are 18 years of age or older are included in this segment. Adults 65 years of age and older had the highest rates of traumatic brain injury-related hospitalisations and fatalities, according to the Centers for Disease Control and Prevention (CDC).
 
By Gender

Based on gender, the traumatic brain injury therapeutics market is segmented into male and female. The male category dominated the market in 2022. Males are more likely than women to suffer from TBI, and they are more likely to do so as a result of physical activities like contact sports, military conflict, and car accidents. As a result, there might be a higher need for therapies catering to male TBI patients' unique requirements.
 
By Cause of Injury

Based on cause of injury, the traumatic brain injury therapeutics market is segmented into falls, motor vehicle traffic, sports and others. The motor vehicle traffic category dominated the market in 2022. The most common causes of TBI include motor vehicle traffic accidents. Therapeutics that cater to the particular requirements of patients who have suffered a TBI from accidents may be in higher demand.
 
By End Users

Based on end users, the traumatic brain injury therapeutics market is segmented into hospitals, neurology clinics, independent pharmacies and others. The automotive category dominated the market in 2022 due to an increase in brain surgeries performed in hospitals and an increase in the number of TBI patients globally. Modern technology is available in hospitals, and trained neurologists use it. This is anticipated to hasten the segment's growth during the forecast period.
 
REGIONAL INSIGHTS

Traumatic Brain Injury Therapeutics Market By Region 
North America is projected to hold the largest share of the traumatic brain injury therapeutics market over the forecast period due to a significant increase in instances connected to falls and other accidents, substantial R&D by FDA scientists, and other causes. The U.S. had the biggest market share in North America for traumatic brain injury therapeutics. The expansion can also be attributed to credible medical facilities nearby, expanding government initiatives, and continental awareness-building campaigns for brain injuries. On the other hand, the Asia Pacific traumatic brain injury therapeutics market is anticipated to grow significantly. Several variables, including an ageing population, an increase in TBI cases, traffic accidents, and violence, cause this. Many interventional procedures have been performed in the Asia Pacific region due to expanding patient affordability and other factors.
 
LIST OF KEY COMPANIES PROFILED:
  • Zimmer Biomet
  • Neuren Pharmaceuticals
  • Teva Pharmaceutical Industries Ltd
  • Medicortex Finland Oy
  • AMARANTUS BIOSCIENCE HOLDINGS, INC.
  • Stemedica Cell Technologies, Inc.
  • BANYAN BIOMARKERS, INC.
  • BioDirection
  • QuesGen Systems, Inc.
  • Neural Analytics, Inc.
  • Oculogica
  • VASOPHARM
  • Johnson & Johnson Services Inc.
  • Smith & Nephew
  • Stryker
  • Medtronic
  • Bioretec Ltd.
  • B.Braun Melsungen AG
  • Arthrex, Inc.
  • Corin
  • Orthofix Medical Inc.
  • Acumed LLC
  • Wright Medical Group N.V.
  • NuVasive Inc.
  • Advance Orthopaedic Solutions
  • Arthrosurface
  • CONMED Corporation
  • Others
REPORT SCOPE AND SEGMENTATION
 
Attributes Details
Market Size in 2022 USD 569.5 Million
Market Forecast in 2030 USD 1036.7 Million
Compound Annual Growth Rate 10.50 %
Unit Revenue (USD Million) and Volume (Kilo Tons)
Segmentation By Treatment, By Route of Administration, By Patient Age, By Gender, By Cause of Injury, By End Users, and By Geography
By Treatment
  • Immediate Emergency Care
  • Medications
  • Surgery
By Route of Administration
  • Parenteral
  • Oral
By Patient Age
  • Children
  • Teenager
  • Elder
By Gender
  • Male
  • Female
By Cause of Injury
  • Falls
  • Motor Vehicle Traffic
  • Sports
  • Others
By End Users
  • Hospitals
  • Neurology Clinics
  • Independent Pharmacies
  • Others
By Region
  • North America: U.S and Canada
  • Europe: Germany, Italy, Russia, U.K, Spain, France, Rest of Europe
  • APAC: China, Australia, Japan, India, South Korea, South East Asia, Rest of Asia Pacific
  • Latin America: Brazil, Argentina, Chile
  • The Middle East And Africa: South Africa, GCC, Rest of MEA
Base Year 2022
Historical Year 2016-2021
Forecast Year 2023-2030
Chapter 1    Preface

    1.1    Report Scope and Description
        1.1.1    Study Purpose
        1.1.2    Target Audience
        1.1.3    USP and Key Offerings
    1.2    Key Benefits for Stakeholders
    1.3    Report Scope

Chapter 2    Report Summary

    2.1    Key Findings
        2.1.1    Top Investment Pockets
    2.2    Market Snapshot: Global Traumatic Brain Injury Therapeutics Market
    2.3    Global Traumatic Brain Injury Therapeutics Market, 2018 – 2028 (US$ Mn)

Chapter 3    COVID 19 Impact Analysis

    3.1    Impact Assessment of COVID-19 Pandemic, By Region
        3.1.1    North America: Impact of COVID-19 Pandemic
        3.1.2    Europe: Impact of COVID-19 Pandemic
        3.1.3    Asia pacific: Impact of COVID-19 Pandemic
        3.1.4    Latin America: Impact of COVID-19 Pandemic
        3.1.5    Middle-East and Africa: Impact of COVID-19 Pandemic
    3.2    Key Strategies Undertaken by Companies to Tackle COVID-19
    3.3    Quarterly Market Revenue by Region 2021 & 2022
    3.4    Pre COVID-19 Market Revenue, By Region, 2016-2019        (USD Million)
    3.5    Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Million)
    3.6    Short Term Dynamics
    3.7    Long Term Dynamics

Chapter 4    Global Traumatic Brain Injury Therapeutics Market, By Treatment Segment Analysis

    4.1    Traumatic Brain Injury Therapeutics Market Overview, By Treatment Segment
        4.1.1    Global Traumatic Brain Injury Therapeutics Market Revenue Share, By Treatment, 2022 & 2028 (Value, %)
    4.2    Immediate Emergency Care
        4.2.1    Traumatic Brain Injury Therapeutics Share Forecast, By Region (USD Million)
        4.2.2    Comparative Revenue Analysis, By Country, 2021 & 2028
        4.2.3    Key Market Trends, Growth Factors, & Opportunities
    4.3    Medications
        4.3.1    Traumatic Brain Injury Therapeutics Share Forecast, By Region (USD Million)
        4.3.2    Comparative Revenue Analysis, By Country, 2021 & 2028
        4.3.3    Key Market Trends, Growth Factors, & Opportunities
    4.4    Surgery
        4.4.1    Traumatic Brain Injury Therapeutics Share Forecast, By Region (USD Million)
        4.4.2    Comparative Revenue Analysis, By Country, 2021 & 2028
        4.4.3    Key Market Trends, Growth Factors, & Opportunities
            
Chapter 5    Global Traumatic Brain Injury Therapeutics Market, By Route of Administration Segment Analysis

    5.1    Traumatic Brain Injury Therapeutics Market Overview, By Route of Administration Segment
        5.1.1    Global Traumatic Brain Injury Therapeutics Market Revenue Share, By Route of Administration, 2022 & 2028 (Value, %)
    5.2    Parenteral
        5.2.1    Traumatic Brain Injury Therapeutics Share Forecast, By Region (USD Million)
        5.2.2    Comparative Revenue Analysis, By Country, 2022 & 2028
        5.2.3    Key Market Trends, Growth Factors, & Opportunities
    5.3    Oral
        5.3.1    Traumatic Brain Injury Therapeutics Share Forecast, By Region (USD Million)
        5.3.2    Comparative Revenue Analysis, By Country, 2022 & 2028
        5.3.3    Key Market Trends, Growth Factors, & Opportunities
            
Chapter 6    Global Traumatic Brain Injury Therapeutics Market, By Patient Age Segment Analysis

    6.1    Traumatic Brain Injury Therapeutics Market Overview, By Patient Age Segment
        6.1.1    Global Traumatic Brain Injury Therapeutics Market Value Share, By Patient Age, 2021 & 2028 (Value, %)
    6.2    Children
        6.2.1    Traumatic Brain Injury Therapeutics Share Forecast, By Region (USD Million)
        6.2.2    Comparative Revenue Analysis, By Country, 2022 & 2028
        6.2.3    Key Market Trends, Growth Factors, & Opportunities
    6.3    Teenager
        6.3.1    Traumatic Brain Injury Therapeutics Share Forecast, By Region (USD Million)
        6.3.2    Comparative Revenue Analysis, By Country, 2022 & 2028
        6.3.3    Key Market Trends, Growth Factors, & Opportunities
    6.4    Elder
        6.4.1    Traumatic Brain Injury Therapeutics Share Forecast, By Region (USD Million)
        6.4.2    Comparative Revenue Analysis, By Country, 2022 & 2028
        6.4.3    Key Market Trends, Growth Factors, & Opportunities
        
Chapter 7    Global Traumatic Brain Injury Therapeutics Market, By Gender Segment Analysis

    7.1    Traumatic Brain Injury Therapeutics Market Overview, By Gender Segment
        7.1.1    Global Traumatic Brain Injury Therapeutics Market Revenue Share, By Gender, 2022 & 2028 (Value, %)
    7.2    Male
        7.2.1    Traumatic Brain Injury Therapeutics Share Forecast, By Region (USD Million)
        7.2.2    Comparative Revenue Analysis, By Country, 2021 & 2028
        7.2.3    Key Market Trends, Growth Factors, & Opportunities
    7.3    Female
        7.3.1    Traumatic Brain Injury Therapeutics Share Forecast, By Region (USD Million)
        7.3.2    Comparative Revenue Analysis, By Country, 2021 & 2028
        7.3.3    Key Market Trends, Growth Factors, & Opportunities
    
Chapter 8    Global Traumatic Brain Injury Therapeutics Market, By Cause of Injury Segment Analysis

    8.1    Traumatic Brain Injury Therapeutics Market Overview, By Cause of Injury Segment
        8.1.1    Global Traumatic Brain Injury Therapeutics Market Revenue Share, By Cause of Injury, 2022 & 2028 (Value, %)
    8.2    Falls
        8.2.1    Traumatic Brain Injury Therapeutics Share Forecast, By Region (USD Million)
        8.2.2    Comparative Revenue Analysis, By Country, 2021 & 2028
        8.2.3    Key Market Trends, Growth Factors, & Opportunities
    8.3    Motor Vehicle Traffic
        8.3.1    Traumatic Brain Injury Therapeutics Share Forecast, By Region (USD Million)
        8.3.2    Comparative Revenue Analysis, By Country, 2021 & 2028
        8.3.3    Key Market Trends, Growth Factors, & Opportunities
    8.4    Sports
        8.4.1    Traumatic Brain Injury Therapeutics Share Forecast, By Region (USD Million)
        8.4.2    Comparative Revenue Analysis, By Country, 2021 & 2028
        8.4.3    Key Market Trends, Growth Factors, & Opportunities
    8.5    Others
        8.5.1    Traumatic Brain Injury Therapeutics Share Forecast, By Region (USD Million)
        8.5.2    Comparative Revenue Analysis, By Country, 2021 & 2028
        8.5.3    Key Market Trends, Growth Factors, & Opportunities
        
Chapter 9    Global Traumatic Brain Injury Therapeutics Market, By End Users Segment Analysis

    9.1    Traumatic Brain Injury Therapeutics Market Overview, By End Users Segment
        9.1.1    Global Traumatic Brain Injury Therapeutics Market Revenue Share, By End Users, 2022 & 2028 (Value, %)
    9.2    Hospitals
        9.2.1    Traumatic Brain Injury Therapeutics Share Forecast, By Region (USD Million)
        9.2.2    Comparative Revenue Analysis, By Country, 2021 & 2028
        9.2.3    Key Market Trends, Growth Factors, & Opportunities
    9.3    Neurology Clinics
        9.3.1    Traumatic Brain Injury Therapeutics Share Forecast, By Region (USD Million)
        9.3.2    Comparative Revenue Analysis, By Country, 2021 & 2028
        9.3.3    Key Market Trends, Growth Factors, & Opportunities
    9.4    Independent Pharmacies
        9.4.1    Traumatic Brain Injury Therapeutics Share Forecast, By Region (USD Million)
        9.4.2    Comparative Revenue Analysis, By Country, 2021 & 2028
        9.4.3    Key Market Trends, Growth Factors, & Opportunities
    9.5    Others
        9.5.1    Traumatic Brain Injury Therapeutics Share Forecast, By Region (USD Million)
        9.5.2    Comparative Revenue Analysis, By Country, 2021 & 2028
        9.5.3    Key Market Trends, Growth Factors, & Opportunities
            
Chapter 10    Traumatic Brain Injury Therapeutics Market – Regional Analysis, 2022 – 2028

    10.1    Traumatic Brain Injury Therapeutics market Overview, by Region Segment
        10.1.1    Global Traumatic Brain Injury Therapeutics market Revenue Share, By Region, 2022 & 2028
        10.1.2    Global Traumatic Brain Injury Therapeutics Market Revenue, By Region, 2017 – 2028 (US$ Mn)
        10.1.3    Global Traumatic Brain Injury Therapeutics market Revenue, By Treatment, 2017 – 2028 (US$ Mn)
        10.1.4    Global Traumatic Brain Injury Therapeutics market Revenue, By Route of Administration, 2017 – 2028 (US$ Mn)
        10.1.5    Global Traumatic Brain Injury Therapeutics Market Revenue, By Patient Age, 2017 – 2028 (US$ Mn)
        10.1.6    Global Traumatic Brain Injury Therapeutics Market Revenue, By Gender, 2017 – 2028 (US$ Mn)
        10.1.7    Global Traumatic Brain Injury Therapeutics Market Revenue, By Cause of Injury, 2017 – 2028 (US$ Mn)
        10.1.8    Global Traumatic Brain Injury Therapeutics Market Revenue, By End Users, 2017 – 2028 (US$ Mn)
    10.2    North America
        10.2.1    North America Traumatic Brain Injury Therapeutics Market Revenue, By Country, 2018 – 2028 (US$ Mn)
        10.2.2    North America Traumatic Brain Injury Therapeutics Market Revenue, By Treatment, 2018 – 2028 (US$ Mn)/(Kilo Tons)
        10.2.3    North America Traumatic Brain Injury Therapeutics Market Revenue, By Route of Administration, 2018 – 2028 (US$ Mn)/(Kilo Tons)
        10.2.4    North America Traumatic Brain Injury Therapeutics Market Revenue, By Patient Age, 2018 – 2028 (US$ Mn)/(Kilo Tons)
        10.2.5    North America Traumatic Brain Injury Therapeutics Market Revenue, By Gender, 2018 – 2028 (US$ Mn)/(Kilo Tons)
        10.2.6    North America Traumatic Brain Injury Therapeutics Market Revenue, By Cause of Injury, 2018 – 2028 (US$ Mn)/(Kilo Tons)
        10.2.7    North America Traumatic Brain Injury Therapeutics Market Revenue, By End Users, 2018 – 2028 (US$ Mn)/(Kilo Tons)
        10.2.8    U.S. Traumatic Brain Injury Therapeutics Market Revenue, 2018 - 2028 (US$ Mn)/ (Kilo Tons)
        10.2.9    Canada Traumatic Brain Injury Therapeutics Market Revenue, 2018 - 2028 (US$ Mn)/ (Kilo Tons)
        10.2.10    Mexico Traumatic Brain Injury Therapeutics Market Revenue, 2018 - 2028 (US$ Mn)/ (Kilo Tons)
    10.3    Europe
        10.3.1    Europe Traumatic Brain Injury Therapeutics Market Revenue, By Country, 2018 – 2028 (US$ Mn)
        10.3.2    Europe Traumatic Brain Injury Therapeutics Market Revenue, By Treatment, 2018 – 2028 (US$ Mn)/(Kilo Tons)
        10.3.3    Europe Traumatic Brain Injury Therapeutics Market Revenue, By Route of Administration, 2018 – 2028 (US$ Mn)/(Kilo Tons)
        10.3.4    Europe Traumatic Brain Injury Therapeutics Market Revenue, By Patient Age, 2018 – 2028 (US$ Mn)/(Kilo Tons)
        10.3.5    Europe Traumatic Brain Injury Therapeutics Market Revenue, By Gender, 2018 – 2028 (US$ Mn)/(Kilo Tons)
        10.3.6    Europe Traumatic Brain Injury Therapeutics Market Revenue, By Cause of Injury, 2018 – 2028 (US$ Mn)/(Kilo Tons)
        10.3.7    Europe Traumatic Brain Injury Therapeutics Market Revenue, By End Users, 2018 – 2028 (US$ Mn)/(Kilo Tons)
        10.3.8    Germany Traumatic Brain Injury Therapeutics Market Revenue, 2018 - 2028 (US$ Mn)/ (Kilo Tons)
        10.3.9    France Traumatic Brain Injury Therapeutics Market Revenue, 2018 - 2028 (US$ Mn)/ (Kilo Tons)
        10.3.10    U.K. Traumatic Brain Injury Therapeutics Market Revenue, 2018 - 2028 (US$ Mn)/ (Kilo Tons)
        10.3.11    Italy Traumatic Brain Injury Therapeutics Market Revenue, 2018 - 2028 (US$ Mn)/ (Kilo Tons)
        10.3.12    Spain Traumatic Brain Injury Therapeutics Market Revenue, 2018 - 2028 (US$ Mn)/ (Kilo Tons)
        10.3.13    Rest of Europe Traumatic Brain Injury Therapeutics Market Revenue, 2018 - 2028 (US$ Mn)/ (Kilo Tons)
    10.4    Asia Pacific
        10.4.1    Asia Pacific Traumatic Brain Injury Therapeutics Market Revenue, By Country, 2018 – 2028 (US$ Mn)
        10.4.2    Asia Pacific Traumatic Brain Injury Therapeutics Market Revenue, By Treatment, 2018 – 2028 (US$ Mn)/(Kilo Tons)
        10.4.3    Asia Pacific Traumatic Brain Injury Therapeutics Market Revenue, By Route of Administration, 2018 – 2028 (US$ Mn)/(Kilo Tons)
        10.4.4    Asia Pacific Traumatic Brain Injury Therapeutics Market Revenue, By Patient Age, 2018 – 2028 (US$ Mn)/(Kilo Tons)
        10.4.5    Asia Pacific Traumatic Brain Injury Therapeutics Market Revenue, By Gender, 2018 – 2028 (US$ Mn)/(Kilo Tons)
        10.4.6    Asia Pacific Traumatic Brain Injury Therapeutics Market Revenue, By Cause of Injury, 2018 – 2028 (US$ Mn)/(Kilo Tons)
        10.4.7    Asia Pacific Traumatic Brain Injury Therapeutics Market Revenue, By End Users, 2018 – 2028 (US$ Mn)/(Kilo Tons)
        10.4.8    China Traumatic Brain Injury Therapeutics Market Revenue, 2018 - 2028 (US$ Mn)/ (Kilo Tons)
        10.4.9    Japan Traumatic Brain Injury Therapeutics Market Revenue, 2018 - 2028 (US$ Mn)/ (Kilo Tons)
        10.4.10    India Traumatic Brain Injury Therapeutics Market Revenue, 2018 - 2028 (US$ Mn)/ (Kilo Tons)
        10.4.11    South Korea Traumatic Brain Injury Therapeutics Market Revenue, 2018 - 2028 (US$ Mn)/ (Kilo Tons)
        10.4.12    South-East Asia Traumatic Brain Injury Therapeutics Market Revenue, 2018 - 2028 (US$ Mn)/ (Kilo Tons)
        10.4.13    Rest of Asia Pacific Traumatic Brain Injury Therapeutics Market Revenue, 2018 - 2028 (US$ Mn)/ (Kilo Tons)
    10.5    Latin America
        10.5.1    Latin America Traumatic Brain Injury Therapeutics Market Revenue, By Country, 2018 – 2028 (US$ Mn)
        10.5.2    Latin America Traumatic Brain Injury Therapeutics Market Revenue, By Treatment, 2018 – 2028 (US$ Mn)/(Kilo Tons)
        10.5.3    Latin America Traumatic Brain Injury Therapeutics Market Revenue, By Route of Administration, 2018 – 2028 (US$ Mn)/(Kilo Tons)
        10.5.4    Latin America Traumatic Brain Injury Therapeutics Market Revenue, By Patient Age, 2018 – 2028 (US$ Mn)/(Kilo Tons)
        10.5.5    Latin America Traumatic Brain Injury Therapeutics Market Revenue, By Gender, 2018 – 2028 (US$ Mn)/(Kilo Tons)
        10.5.6    Latin America Traumatic Brain Injury Therapeutics Market Revenue, By Cause of Injury, 2018 – 2028 (US$ Mn)/(Kilo Tons)
        10.5.7    Latin America Traumatic Brain Injury Therapeutics Market Revenue, By End Users, 2018 – 2028 (US$ Mn)/(Kilo Tons)
        10.5.8    Brazil Traumatic Brain Injury Therapeutics Market Revenue, 2018 - 2028 (US$ Mn)/ (Kilo Tons)
        10.5.9    Argentina Traumatic Brain Injury Therapeutics Market Revenue, 2018 - 2028 (US$ Mn)/ (Kilo Tons)
        10.5.10    Rest of Latin America Traumatic Brain Injury Therapeutics Market Revenue, 2018 - 2028 (US$ Mn)/ (Kilo Tons)
    10.6    The Middle-East and Africa
        10.6.1    The Middle-East and Africa Traumatic Brain Injury Therapeutics Market Revenue, By Country, 2018 – 2028 (US$ Mn)
        10.6.2    The Middle-East and Africa Traumatic Brain Injury Therapeutics Market Revenue, By Treatment, 2018 – 2028 (US$ Mn)/(Kilo Tons)
        10.6.3    The Middle-East and Africa Traumatic Brain Injury Therapeutics Market Revenue, By Route of Administration, 2018 – 2028 (US$ Mn)/(Kilo Tons)
        10.6.4    The Middle-East and Africa Traumatic Brain Injury Therapeutics Market Revenue, By Patient Age, 2018 – 2028 (US$ Mn)/(Kilo Tons)
        10.6.5    The Middle-East and Africa Traumatic Brain Injury Therapeutics Market Revenue, By Gender, 2018 – 2028 (US$ Mn)/(Kilo Tons)
        10.6.6    The Middle-East and Africa Traumatic Brain Injury Therapeutics Market Revenue, By Cause of Injury, 2018 – 2028 (US$ Mn)/(Kilo Tons)
        10.6.7    The Middle-East and Africa Traumatic Brain Injury Therapeutics Market Revenue, By End Users, 2018 – 2028 (US$ Mn)/(Kilo Tons)
        10.6.8    GCC Countries Traumatic Brain Injury Therapeutics Market Revenue, 2018 - 2028 (US$ Mn)/ (Kilo Tons)
        10.6.9    South Africa Traumatic Brain Injury Therapeutics Market Revenue, 2018 - 2028 (US$ Mn)/ (Kilo Tons)
        10.6.10    Rest of Middle-East Africa Traumatic Brain Injury Therapeutics Market Revenue, 2018 - 2028 (US$ Mn)/ (Kilo Tons)

Chapter 11    Traumatic Brain Injury Therapeutics Market – Industry Analysis

    11.1    Introduction
    11.2    Market Drivers
        11.2.1    Driving Factor 1 Analysis
        11.2.2    Driving Factor 2 Analysis
    11.3    Market Restraints
        11.3.1    Restraining Factor Analysis
    11.4    Market Opportunities
        11.4.1    Market Opportunity Analysis
    11.5    Porter’s Five Forces Analysis
    11.6    PEST Analysis
    11.7    Regulatory Landscape
    11.8    Technology Landscape
    11.9      Value Chain Analysis

Chapter 12    Competitive Landscape

    12.1    Company Market Share Analysis – 2022
        12.1.1    Global Traumatic Brain Injury Therapeutics market: Company Market Share, 2022
        12.1.2    Global Traumatic Brain Injury Therapeutics Market: Company Market Share, 2022
    12.2    Strategic Developments
        12.2.1    Acquisitions & Mergers
        12.2.2    New Product Launch
        12.2.3    Regional Expansion
    12.3    Company Strategic Developments – Heat Map Analysis

Chapter 13    Company Profiles

    13.1    Broadcom
        13.1.1    Company Overview
        13.1.2    Key Executives
        13.1.3    Product Portfolio
        13.1.4    Financial Overview
        13.1.5    Operating Business Segments
        13.1.6    Business Segment Performance
        13.1.7    Recent Developments
    13.2    EMCORE Corporation
    13.3    APIC Corporation
    13.4    Optical Zonu Corp
    13.5    Gooch & Housego PLC
    13.6    ViaLite
    13.7    Global Invacom
    13.8    HUBER+SUHNER
    13.9    Glenair
    13.10    SEIKOH GIKEN CO., LTD.
    13.11    II-VI Incorporated
    13.12    DEV Systemtechnik GmbH
    13.13    Syntonics LLC
    13.14    ETL Systems Ltd
    13.15    Narda-MITEQ
    13.16    Olabs Technology Company Limited
    13.17    RFOptic Ltd
    13.18    Elkay
    13.19    MicroComp Nordic AB
    13.20    Others

Chapter 14    Research Methodology

    14.1    Research Methodology
    14.2    Phase I – Secondary Research
    14.3    Phase II - Data Modeling
        14.3.1    Company Share Analysis Model
        14.3.2    Revenue Based Modelling
    14.4    Phase III – Primary Research
    14.5    Research Limitations
        14.5.1    Assumptions
No Methodology
No Available